This Breakthrough Cancer Treatment Has Prevented Leukemia Relapse for Over a Decade
This Breakthrough Cancer Treatment Has Prevented Leukemia Relapse for Over a Decade
Super Effective
We already knew CAR T-cell treatment was incredibly good at killing tumor cells. But now we know it works for a ridiculously long time.
Sofia Quaglia
Updated Feb. 02, 2022 12:23PM ET / Published Feb. 02, 2022 11:00AM ET
Courtesy UPenn Medicine
Doug Olson was 49 years old with a wife and four kids when he was diagnosed with chronic lymphocytic leukemia in 1996. His initial treatments were pretty successful, but by 2010 almost 50 percent of his bone marrow was cancerous again.
Thats when he enrolled into a clinical trial of a new cancer therapy led by his oncologist, David Porter from the University of Pennsylvanias Perelman Center for Advanced Medicine, together with one other patient.
The experimental treatment, also known as CAR T-cell therapy, would tweak Olson's own immune cells to spot and kill leukemia cells, and reintroduce them into his body through blood infusionsomething that previously showed promise only in trials on mice.
Olson started physically feeling the results after just a couple of weeks. Thats when Dr. Porter came into my hospital room and he announced, hot off the press, that 18 percent of my white cells were CAR T-cells, Olson said during a press conference Tuesday. I will tell you that moment, I was absolutely convinced that this thing was working and that I was gonna be okay.
The next week, Porter told Olson the clinicians couldnt find a single cancer cell in his body.
Its been more than 10 years now, and Olson is still cancer free.
more...
https://www.thedailybeast.com/car-t-cell-therapy-prevented-leukemia-cancer-remission-in-patients-for-over-10-years?ref=home